Boston Scientific · 6 hours ago
Senior AI/ Vision Engineer
Boston Scientific is a leader in medical science committed to solving significant health industry challenges. The Senior AI/ Vision Engineer will design and build machine vision and automated control systems for the production of medical devices, collaborating through all stages of development from concept to troubleshooting.
Health CareMedicalMedical Device
Responsibilities
Design vision systems including specifying cameras, lighting, and lensing requirements
Lead or participate on project teams to develop clear specifications, evaluate feasibility of concepts, and provide formal estimates for machine vision applications
Provide leadership on championing functional best practices and new technology initiatives
Influence and define functional, departmental, and divisional procedures through involvement with cross-functional engineering initiatives
Lead project teams that include Designers, Engineers, and Technicians in the design, assembly, and debugging of equipment
Integrate machine vision systems into PC- or PLC-based systems
Explain factual information of limited complexity to others in straightforward situations
Organize, present, and explain data/information to internal and external audiences
Qualification
Required
Minimum of 3 years' experience in a related job category
Bachelor's degree
Ability to travel up to 20%
No sponsorship available
Preferred
Proven ability to influence without authority
Boston Scientific experience
Certified Vision Professional – Basic
Fluent in programming languages, packages, and concepts: C++, C# / .NET, Python, Open C, Communication protocols and IP configuration
Fluent in machine vision platforms: Cognex ISE, Cognex ISVS, Cognex V-Pro, Cognex Designer, Cognex OneVision, Cognex VIDI, Keyence XG VisionEditor / VisionTerminal, Keyence VS Creator, Keyence IV-Navigator / Smart Navigator
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
2026-01-13
2026-01-13
2026-01-13
Company data provided by crunchbase